Repurposing pentoxifylline for the treatment of fibrosis: an overview
Fibrosis is a potentially debilitating disease with high morbidity rates. It is estimated that half of all deaths that occur in the USA are attributed to fibrotic disorders. Fibrotic disorders are characterized primarily by disruption in the extracellular matrix deposition and breakdown equilibrium,...
Auteurs principaux: | Wen, W, Lee, S, Siang, R, Koh, R |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Springer Nature
2017
|
Documents similaires
-
Pentoxifylline in patients with oral submucous fibrosis
par: Ashwini Deshpande, et autres
Publié: (2015-01-01) -
Efficacy of pentoxifylline in the management of oral submucous fibrosis
par: Santosh Patil, et autres
Publié: (2014-01-01) -
Pentoxifylline Inhibits Pulmonary Fibrosis by Regulating Cellular Senescence in Mice
par: Yifan Lin, et autres
Publié: (2022-05-01) -
Pentoxifylline in the Treatment of Acute Alcoholic Hepatitis
par: Arun S, et autres
Publié: (2014-07-01) -
Pentoxifylline: An Immunomodulatory Drug for the Treatment of COVID-19
par: Hiren A. Dhameliya, et autres
Publié: (2020-05-01)